Navigation Links
Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones
Date:9/17/2009

emia/Default.aspx" target="_new">Video and General Information on Anemia on Blood: The Vital Connection

Reporters who wish to receive a copy of the study or arrange an interview with Dr. Greenberg may contact Patrick Irelan at 202-776-0544 or pirelan@hematology.org.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It features hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.

Blood, the official journal of ASH, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers weekly and is available in print and online at www.bloodjournal.org.


'/>"/>
SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
2. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
3. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
4. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
5. Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
6. Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu
7. New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
8. Yoga Benefits Back-Pain Patients
9. Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
10. CRESTOR(R) Reduced Risk of Cardiovascular Events in Elderly Patients in New Analysis of Jupiter
11. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-- CryoLife,Inc. (NYSE:...iovasculartissueprocessingcompany,announcedtodayth...ray21stAnnualHealthCareConferenceatTheNewYorkPalac...sidentandchiefexecutiveofficerofCryoLife,Inc.,will...tdevelopmentsandhostaquestionandanswersessionat4:3...
(Date:11/23/2009)...,Tenn.,Nov.23/PRNewswire-FirstCall/-- CumberlandPh...newtop-lineresultsfromastudyevaluatingthesafetyand...feverinhospitalizedburnpatients. ,, Statistical...cingfeverinburnpatientsoverthefirst24hoursoftreatm...orthirddegreeburnscoveringmorethan10percenttotalbo...
(Date:11/23/2009)...IRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc.,thenatio...intheemergencymedicalservices(EMS)andrespiratoryma...estoitsseniormanagementteam.Thenewexecutivesinclud...executivevicepresidentandgeneralcounsel;SteveLacke...le,executivevicepresidentofcorporatedevelopment. ,...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 1Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 3Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 4Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 1Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 2
...shy; May 14, 2007-Acceleron Pharma, Inc., a,biopha...e treatment,of musculoskeletal, metabolic and canc...preclinical study with ACE-031 that,demonstrated t...,and strength in normal mice and in murine models ...egulators of muscle to,increase muscle mass and st...
...BUSINESS WIRE)--May 15, 2007 - Reata,Pharmaceutica...icle,in the May 2007 issue of the journal Cancer R...2 development candidate for cancer,was highly eff...,and that the drug inhibits signaling activity of ...s., The article, "The Novel Triterpenoid C-28 Meth...
Other Medicine Technology:Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 2Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 3RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 2RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 3
(Date:11/23/2009)...an three-quarters getting chemo deal with insomnia...hDay News) -- Insomnia and sleep disorders affect ...oing chemotherapy, a rate nearly three times highe... finds. , The problem is more common in younger...s, said University of Rochester Medical Center res...
(Date:11/23/2009)... CENTERCITY,Minn.,Nov.23/PRNewswire/--Hazelden,the...center,todayannouncedtheleadershipteamforitsnewrec...tyinNaplesisscheduledtoopeninlateMarch2010,andwill...s,includingafullarrayoffamilyandoutpatientservices...rectorofHazelden,sfacilityinNaples,withBrendaIliff...
(Date:11/23/2009)... WASHINGTON,Nov.23/PRNewswire-USNewswire/-- The A...,slargestindividualmembershipassociationofstateleg...ativeTimScott forpre-filinga constitutionalamendme...lthcarechoices.SouthCarolinanowbecomesthe24thstate...islationmodeledafterALEC,s FreedomofChoiceinHealth...
(Date:11/23/2009)...EN, N.J. The Center for Science Writings at Steve...tion of God," a talk by Robert Wright, journalist ... 2, 2009, 4:00-5:30 p.m. at the Babbio Center for ... and open to the public and the media., In his n...urnalist Robert Wright, renowned for his popular w...
(Date:11/23/2009)...rsity of Alberta graduate student Jennifer Heys wa...ore education in Ugandan communities about contrac...iduals and their desire to bear more children, was...red last week at the International Conference on F...tudied at the School of Public Health, spent six m...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2
...inical,Meeting and Exhibition -- Omnicell, Inc., (...tions to acute healthcare facilities, and Brigham ... of Harvard Medical School located in,the heart ...ion management system. With the integration of the...
...od costs, many,families are economizing on groceri...trition. At about 25 cents per 8-ounce glass, on a...y than almost any other beverage option in the,sup...m,their grocery lists, the National got milk? Camp...
... announced today that Dr. Jonathan White will join...Vice President of Haemonetics, effective December ... responsibility for leading development of the nex...As the global leader in blood management solutions...
...tories, Inc. (Nasdaq: IDXX ), today announced th...e Vice President, Instrument Research and Developm... Dr. Brown will oversee instrument development, ma... IDEXX,s strategy of technological innovation in d...
...Sciences, Inc. (Nasdaq: HGSI ) today announced t...he results of ACHIEVE 2/3, its Phase 3 trial of Al...titis C. , , (Logo: http://www.newscom.com/c...am Eastern Time. , , Investors may listen to ...
...irms what we already,know -- that U.S. consumers h...onths. More than one-third have made measurable c... according to Booz & Company (October 2008).,T...re,is a popular myth that fresh produce is too exp...
Other Medicine News:Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 2Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 3Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 3Health News:Dr. Jonathan White Joins Haemonetics as Head of Research and Development 2Health News:IDEXX Laboratories Names William Brown Corporate Vice President 2Health News:Human Genome Sciences to Sponsor Conference Call 2Health News:Healthy Eating and Good Nutrition Go Hand-in-Hand in Tight Economic Times 2
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: